Epsilon M&A Deal Report - Risdon Pharma Development

Transaction Multiples for the Valuation of Private Companies

Rexam > Risdon Pharma Development

Announced Date : 04 June 2003

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Rexam

Target: Risdon Pharma Development

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology, Industrial Goods

Business Description :

> Risdon Pharma Development S.A. manufactures medical devices ...

No EMAT : 79050

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Industrial Goods) = 875

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
20/04/2015 Tornum Lidkopings Platteknik Sweden 0
02/12/2011 The Babcock & Wilcox Company Anlagenbau und Fördertechnik Arthur Loibl Germany 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database